Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ZYCLARA | Bausch Health Companies | N-022483 RX | 2010-03-25 | 2 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
aldara | New Drug Application | 2023-10-05 |
imiquimod | NDA authorized generic | 2024-01-11 |
imiquimod 5% / levocetirizine dihydrochloride 1% / niacinamide 2% | unapproved drug other | 2019-04-23 |
imiquimod 5% / levocetirizine dihydrochloride 1% / tretinoin 0.05% | unapproved drug other | 2019-04-23 |
imiquimod 5% / niacinamide 4% | unapproved drug other | 2019-05-06 |
imiquimod 5% / salicylic acid 30% / tretinoin 0.1% | unapproved drug other | 2019-05-06 |
imiquimod 5% / tretinoin 0.025% | unapproved drug other | 2019-05-06 |
zyclara | New Drug Application | 2024-01-08 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
actinic keratosis | — | D055623 | L57.0 |
basal cell carcinoma | — | D002280 | — |
condylomata acuminata | EFO_0007147 | D003218 | A63.0 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Imiquimod, Zyclara, Bausch | |||
10918635 | 2030-04-30 | U-172, U-1455 | |
11202752 | 2030-04-30 | U-172, U-1455 | |
8222270 | 2029-12-11 | U-68 | |
8236816 | 2029-12-11 | U-68 | |
8299109 | 2029-12-11 | U-68 | |
10238644 | 2029-12-11 | U-68 | |
11318130 | 2029-12-11 | U-68 | |
8598196 | 2029-08-18 | U-172, U-1455 | |
10238645 | 2029-08-18 | U-172, U-1455 | |
Imiquimod, Aldara, Bausch | |||
7696159 | 2024-04-01 | DP | U-1047, U-1048 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Actinic keratosis | D055623 | — | L57.0 | 2 | 6 | 9 | 11 | 6 | 34 |
Basal cell neoplasms | D018295 | — | — | 1 | 1 | 5 | 4 | 2 | 13 |
Basal cell carcinoma | D002280 | — | — | 1 | 1 | 5 | 2 | 3 | 12 |
Condylomata acuminata | D003218 | EFO_0007147 | A63.0 | — | 1 | 2 | 1 | — | 4 |
Hutchinson's melanotic freckle | D018327 | — | — | — | 1 | 2 | 1 | 1 | 4 |
Keratosis | D007642 | — | — | — | — | — | 3 | 1 | 4 |
Papillomaviridae | D027383 | — | — | — | 1 | — | 1 | 1 | 3 |
Warts | D014860 | — | B07 | — | 1 | — | 1 | — | 2 |
Alopecia areata | D000506 | EFO_0004192 | L63 | — | — | — | 2 | — | 2 |
Hiv | D006678 | — | O98.7 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cervical intraepithelial neoplasia | — | — | D06 | 2 | 3 | 5 | — | 4 | 12 |
Human influenza | D007251 | EFO_0007328 | J11.1 | 1 | — | 2 | — | 1 | 4 |
Squamous intraepithelial lesions | D000081483 | — | — | — | 1 | 2 | — | 1 | 4 |
Papillomavirus infections | D030361 | — | — | — | — | 3 | — | — | 3 |
Hepatitis b | D006509 | — | — | — | 2 | 2 | — | — | 2 |
Hiv infections | D015658 | EFO_0000764 | B20 | — | — | 2 | — | — | 2 |
Cutaneous leishmaniasis | D016773 | — | B55.1 | — | 1 | 1 | — | — | 2 |
Localized scleroderma | D012594 | EFO_1001361 | L94.0 | — | — | 2 | — | — | 2 |
Extramammary paget disease | D010145 | — | — | — | — | 1 | — | — | 1 |
Inflammatory bowel diseases | D015212 | EFO_0003767 | — | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Melanoma | D008545 | — | — | 8 | 3 | — | — | — | 10 |
Glioblastoma | D005909 | EFO_0000515 | — | 5 | 1 | — | — | — | 5 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | 3 | — | — | — | 5 |
Neoplasms | D009369 | — | C80 | 3 | 1 | — | — | 1 | 4 |
Colorectal neoplasms | D015179 | — | — | 3 | 1 | — | — | — | 3 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 1 | — | — | 1 | 3 |
Fallopian tube neoplasms | D005185 | — | — | 1 | 1 | — | — | 1 | 3 |
Prostatic neoplasms | D011471 | — | C61 | 2 | 2 | — | — | — | 3 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 1 | — | — | 1 | 3 |
Uterine cervical neoplasms | D002583 | HP_0030159 | — | 1 | 2 | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glioma | D005910 | EFO_0000520 | — | 5 | — | — | — | — | 5 |
Healthy volunteers/patients | — | — | — | 4 | — | — | — | — | 4 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | 2 | — | — | — | — | 2 |
Mycosis fungoides | D009182 | — | C84.0 | 1 | — | — | — | 1 | 2 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | 2 | — | — | — | — | 2 |
Astrocytoma | D001254 | EFO_0000271 | — | 2 | — | — | — | — | 2 |
Ependymoma | D004806 | — | — | 2 | — | — | — | — | 2 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | — | — | — | — | 1 |
Urinary bladder neoplasms | D001749 | — | C67 | 1 | — | — | — | — | 1 |
Cholangiocarcinoma | D018281 | — | C22.1 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Peritoneal neoplasms | D010534 | — | — | — | — | — | — | 1 | 1 |
Chronic disease | D002908 | — | — | — | — | — | — | 1 | 1 |
Pruritus | D011537 | HP_0000989 | L29 | — | — | — | — | 1 | 1 |
Vulvar neoplasms | D014846 | — | C51 | — | — | — | — | 1 | 1 |
Psoriasis | D011565 | EFO_0000676 | L40 | — | — | — | — | 1 | 1 |
Drug common name | Imiquimod |
INN | imiquimod |
Description | Imiquimod is an imidazoquinoline fused [4,5-c] carrying isobutyl and amino substituents at N-1 and C-4 respectively. A prescription medication, it acts as an immune response modifier and is used to treat genital warts, superficial basal cell carcinoma, and actinic keratosis. It has a role as an antineoplastic agent and an interferon inducer. |
Classification | Small molecule |
Drug class | immunomodulators |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(C)Cn1cnc2c(N)nc3ccccc3c21 |
PDB | — |
CAS-ID | 99011-02-6 |
RxCUI | — |
ChEMBL ID | CHEMBL1282 |
ChEBI ID | 36704 |
PubChem CID | 57469 |
DrugBank | DB00724 |
UNII ID | P1QW714R7M (ChemIDplus, GSRS) |